211 related articles for article (PubMed ID: 28980494)
1. Genetic risk factors for pediatric-onset multiple sclerosis.
Gianfrancesco MA; Stridh P; Shao X; Rhead B; Graves JS; Chitnis T; Waldman A; Lotze T; Schreiner T; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee M; Krupp L; Gorman M; Benson L; Rodriguez M; Mar S; Kahn I; Rose J; Roalstad S; Casper TC; Shen L; Quach H; Quach D; Hillert J; Hedstrom A; Olsson T; Kockum I; Alfredsson L; Schaefer C; Barcellos LF; Waubant E;
Mult Scler; 2018 Dec; 24(14):1825-1834. PubMed ID: 28980494
[TBL] [Abstract][Full Text] [Related]
2. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution.
Ziaei A; Lavery AM; Shao XM; Adams C; Casper TC; Rose J; Candee M; Weinstock-Guttman B; Aaen G; Harris Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Hart J; Waldman AT; Barcellos LF; Waubant E
Mult Scler; 2022 Aug; 28(9):1330-1339. PubMed ID: 35000467
[TBL] [Abstract][Full Text] [Related]
3. Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis.
Horton MK; Shim JE; Wallace A; Graves JS; Aaen G; Greenberg B; Mar S; Wheeler Y; Weinstock-Guttman B; Waldman A; Schreiner T; Rodriguez M; Tillema JM; Chitnis T; Krupp L; Casper TC; Rensel M; Hart J; Quach HL; Quach DL; Schaefer C; Waubant E; Barcellos LF
Mult Scler; 2023 Apr; 29(4-5):505-511. PubMed ID: 36755464
[TBL] [Abstract][Full Text] [Related]
4. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
[TBL] [Abstract][Full Text] [Related]
5. Genetic factors for susceptibility to and manifestations of neuromyelitis optica.
Matsushita T; Masaki K; Isobe N; Sato S; Yamamoto K; Nakamura Y; Watanabe M; Suenaga T; Kira JI;
Ann Clin Transl Neurol; 2020 Nov; 7(11):2082-2093. PubMed ID: 32979043
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis.
Kular L; Liu Y; Ruhrmann S; Zheleznyakova G; Marabita F; Gomez-Cabrero D; James T; Ewing E; Lindén M; Górnikiewicz B; Aeinehband S; Stridh P; Link J; Andlauer TFM; Gasperi C; Wiendl H; Zipp F; Gold R; Tackenberg B; Weber F; Hemmer B; Strauch K; Heilmann-Heimbach S; Rawal R; Schminke U; Schmidt CO; Kacprowski T; Franke A; Laudes M; Dilthey AT; Celius EG; Søndergaard HB; Tegnér J; Harbo HF; Oturai AB; Olafsson S; Eggertsson HP; Halldorsson BV; Hjaltason H; Olafsson E; Jonsdottir I; Stefansson K; Olsson T; Piehl F; Ekström TJ; Kockum I; Feinberg AP; Jagodic M
Nat Commun; 2018 Jun; 9(1):2397. PubMed ID: 29921915
[TBL] [Abstract][Full Text] [Related]
7. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
[TBL] [Abstract][Full Text] [Related]
8. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
[TBL] [Abstract][Full Text] [Related]
9. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
[TBL] [Abstract][Full Text] [Related]
10. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.
Bronson PG; Caillier S; Ramsay PP; McCauley JL; Zuvich RL; De Jager PL; Rioux JD; Ivinson AJ; Compston A; Hafler DA; Sawcer SJ; Pericak-Vance MA; Haines JL; ; Hauser SL; Oksenberg JR; Barcellos LF
Hum Mol Genet; 2010 Jun; 19(11):2331-40. PubMed ID: 20211854
[TBL] [Abstract][Full Text] [Related]
11. A higher burden of multiple sclerosis genetic risk confers an earlier onset.
Misicka E; Davis MF; Kim W; Brugger SW; Beales J; Loomis S; Bronson PG; Briggs FB
Mult Scler; 2022 Jul; 28(8):1189-1197. PubMed ID: 34709090
[TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1 polymorphism and susceptibility to multiple sclerosis in the Middle East North Africa region: A systematic review and meta-analysis.
Mohajer B; Abbasi N; Pishgar F; Abdolalizadeh A; Ebrahimi H; Razaviyoun T; Mohebbi F; Eskandarieh S; Sahraian MA
J Neuroimmunol; 2018 Aug; 321():117-124. PubMed ID: 29957381
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Cdx2 VDR gene polymorphism rs11568820 in association with multiple sclerosis in Slovaks.
Čierny D; Dobrota D; Kantorová E; Malicherová B; Škereňová M; Javor J; Kurča E; Lehotský J
Neurol Res; 2023 Oct; 45(10):912-918. PubMed ID: 37581270
[TBL] [Abstract][Full Text] [Related]
14. Infectious mononucleosis-linked HLA class I single nucleotide polymorphism is associated with multiple sclerosis.
Jafari N; Broer L; Hoppenbrouwers IA; van Duijn CM; Hintzen RQ
Mult Scler; 2010 Nov; 16(11):1303-7. PubMed ID: 20736246
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis in families: risk factors beyond known genetic polymorphisms.
Akkad DA; Lee DH; Bruch K; Haghikia A; Epplen JT; Hoffjan S; Linker RA
Neurogenetics; 2016 Apr; 17(2):131-5. PubMed ID: 26865406
[TBL] [Abstract][Full Text] [Related]
16. Highly conserved extended haplotypes of the major histocompatibility complex and their relationship to multiple sclerosis susceptibility.
Goodin DS; Khankhanian P; Gourraud PA; Vince N
PLoS One; 2018; 13(2):e0190043. PubMed ID: 29438392
[TBL] [Abstract][Full Text] [Related]
17. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
[TBL] [Abstract][Full Text] [Related]
18. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
19. Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1*15:01 Status.
Binder MD; Fox AD; Merlo D; Johnson LJ; Giuffrida L; Calvert SE; Akkermann R; Ma GZ; ; Perera AA; Gresle MM; Laverick L; Foo G; Fabis-Pedrini MJ; Spelman T; Jordan MA; Baxter AG; Foote S; Butzkueven H; Kilpatrick TJ; Field J
PLoS Genet; 2016 Mar; 12(3):e1005853. PubMed ID: 26990204
[TBL] [Abstract][Full Text] [Related]
20. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
Gourraud PA; McElroy JP; Caillier SJ; Johnson BA; Santaniello A; Hauser SL; Oksenberg JR
Ann Neurol; 2011 Jan; 69(1):65-74. PubMed ID: 21280076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
